When Perfect is the Enemy of Good: Investigators Compare Rigorous Clinical Trial Data to Real-World Experience

… Using a real-world cohort of US veterans, researchers examine the effectiveness of durvalumab …

New Registry Aims to Expand Knowledge of Lung Cancer Treatment During Pregnancy

… spearheading the effort at Dana Farber, says the need for research on cancer therapies for pregnant patients is urgent …

TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan

… Benjamin C. Creelan shares his passion for cell therapy research and insights into current data. … TIL Therapy Endures …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …

Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds

… Researchers evaluating the clinical significance of …

Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration

… to target this oncogenic driver. Get up to date as researchers from Roswell Park Comprehensive Cancer Center …

Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy

… comparing outcomes of various treatment regimens in the search for the best-performing approach. … Challenges of …

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

… Researchers say increased screening of at-risk populations, …

Mesothelioma Patients Experienced Higher Levels of Toxicity on CheckMate743 Regimen Than Reported in Clinical Trials

… of unresectable pleural mesothelioma. 1  However, research published last month in the  Journal of Thoracic … Vincent’s Hospital, Darlinghurst, Australia, and fellow researchers retrospectively collected demographic and … doi:10.1016/S1470-2045(18)30765-4   … PATIENT RESEARCH ADVOCATE ANGUS PRATT REFLECTS ON THE PAST YEAR OF …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… patients when guidelines and protocols vary and more research is needed. … Recurrence Remains a Risk Even for …

Small, High PLCG2-Expressing Intratumoral Cells May Drive Metastasis

… In the search to understand the mechanisms of metastasis, researchers have expanded the spectrum of SCLC clinical …

Dr. Patrick Forde Discusses Excitement Around Neoadjuvant Immunotherapy for Lung Cancer

… Forde, who is director of the Thoracic Oncology Clinical Research Program and associate professor of Oncology at Johns …